This episode, especially aimed at patients with Rheumatoid Arthritis, features Marleen van de Sande, rheumatologist at Amsterdam UMC, and Frank van Empel, a patient with RA. The episode explores the Episora trial, a major study that uses AI to help determine which medication is most effective for each patient, offering a more efficient alternative to the current trial-and-error approach.
Methylomic Matters is a podcastseries by the METHYLOMIC project: a program committed to bringing personalised treatment-selection in Crohn’s disease and other immune-mediated inflammatory diseases to clinical practice.